AXOGEN, INC. (AXGN)

Director Wendell Amy McBride 🟢 acquired 28.3K shares (1 derivative) of Axogen, Inc. (AXGN) Transaction Date: Jun 19, 2026 | Filing ID: 000013

AXOGEN, INC. (AXGN)

Director THOMAS PAUL 🟢 acquired 37.7K shares (1 derivative) of Axogen, Inc. (AXGN) Transaction Date: Jun 19, 2026 | Filing ID: 000078

AXOGEN, INC. (AXGN)

Director TYNDALL JOSEPH A. 🟢 acquired 28.3K shares (1 derivative) of Axogen, Inc. (AXGN) Transaction Date: Jun 19, 2026 | Filing ID: 000077

AXOGEN, INC. (AXGN)

Director JOHNSON JOHN 🟢 acquired 28.3K shares (1 derivative) of Axogen, Inc. (AXGN) Transaction Date: Jun 19, 2026 | Filing ID: 000006

SILENCE THERAPEUTICS PLC (SLN)

(10% Negative) SILENCE THERAPEUTICS PLC (SLN) Announces Delay in upon Trials for connection wit Due to Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment